Seeing Is Believing
Currently out of the existing stock ratings of Raymond Myers, 7 are a BUY (70%), 3 are a HOLD (30%).
Analyst Raymond Myers, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 29.03% achieved within 205 days. Previously, Raymond Myers worked at BENCHMARK.
Raymond Myers’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HSKA, Heska at 07-May-2018.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$75
$25.67 (52.04%)
$85
10 days ago
(11-Nov-2024)
4/9 (44.44%)
$23.67 (46.11%)
31
Buy
$65
$15.67 (31.77%)
$67
15 days ago
(06-Nov-2024)
10/12 (83.33%)
$14.51 (28.74%)
151
Buy
$67
$17.67 (35.82%)
$75
15 days ago
(06-Nov-2024)
9/10 (90%)
$16.51 (32.70%)
77
Buy
$65
$15.67 (31.77%)
$75
15 days ago
(06-Nov-2024)
0/5 (0%)
$14.51 (28.74%)
Buy
$75
$25.67 (52.04%)
$95
15 days ago
(06-Nov-2024)
2/11 (18.18%)
$24.51 (48.54%)
39
What Year was the first public recommendation made by Raymond Myers?